Dennis Donovan, Ph.D., of the Alcohol and Drug Abuse Institute at the University of Washington is the Principal Investigator for the Seattle component of this multi-site clinical trial. The goal is to determine whether improvement in treatment outcomes can be achieved by various combinations of drug and behavioral interventions. All three interventions will include a component supporting compliance to medications and reduction in drinking. Men and women, age 18 and above, with a current diagnosis of alcohol dependence are eligible for the study. Subjects must be 18 years of age or older.
Participation includes a free diagnostic assessment, a physical and laboratory evaluation.
The subjects must be between 21 and 65, have no major medical problems, and be willing and able to become drug-free. The subjects must be right-handed and free of seizure disorder.